Strategic partnerships IFE actively collaborates with global industry and research partners across nuclear, CCUS, radiopharmaceuticals, and material science. This indicates receptiveness to joint ventures, technology licensing, and co-development projects with suppliers or service providers that can augment their capabilities and funding.

Nuclear and CCUS focus With hosting the OECD Halden Reactor Project and ongoing CCUS joint programs, there is a clear emphasis on advanced nuclear safety, materials research, and CO2-related technologies. Vendors and researchers offering testing facilities, simulation tools, or specialized analytical services in these domains are well-positioned for collaboration or commercialization opportunities.

Regional and global footprint IFE operates from Norway and serves more than 30 countries, signaling a broad international demand for energy research solutions. Sales opportunities exist for multinational suppliers, training providers, and software platforms that can scale across borders and align with European clean energy and critical materials priorities.

Digital and tech stack Adoption of tools like SAP, iCIMS, LabVIEW, and Microsoft 365 suggests a structured enterprise environment open to technology-enabled services, data analytics, project management, and workforce solutions. Potential upsell areas include enterprise software, data analytics, visualization, and cloud-based collaboration tools.

Funding and growth signals Historical partnerships and acquisition activity in radiopharmacy and related fields indicate an ecosystem with capital movement and strategic exits. Opportunities exist to engage in funded R&D collaborations, grant-backed pilots, or technology transfer arrangements with potential for portfolio expansion.